Download PowerPoint File

Description: ESC17 Presentation Slides | GLAGOV: Effect of Evolocumab on Composition of CAD

Date: August 29, 2017    

Clinical Topics: Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Atherosclerotic Disease (CAD/PAD), Lipid Metabolism, Novel Agents

Keywords: ESC Congress, ESC17 Slides, Coronary Artery Disease, Antibodies, Monoclonal, Proprotein Convertases, Dyslipidemias, Primary Prevention